CFDE Data Portal | Search DDB1

	Label	Description
	AREG Gene (Entity type)	ENSG00000109321 - amphiregulin
	PR002550 Project (Entity type)	We report an enantioselective protein affinity selection mass spectrometry screening approach (EAS-M...
	SU004208 Subject (Entity type)	A subject from Metabolomics produced as part of the PR002550 project
	DDB1 Gene (Entity type)	ENSG00000167986 - damage specific DNA binding protein 1
	DCAF6 Gene (Entity type)	ENSG00000143164 - DDB1 and CUL4 associated factor 6
	DDB1 associations Collection (Entity type)	Associations for DDB1_associations
	DCAF10 Gene (Entity type)	ENSG00000122741 - DDB1 and CUL4 associated factor 10
	DDB1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE102505 5 V 0 TUNICAMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE166914 1 V 2 ABEMACICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

AREG

ENSG00000109321 - amphiregulin

PR002550

We report an enantioselective protein affinity selection mass spectrometry screening approach (EAS-M...

SU004208

A subject from Metabolomics produced as part of the PR002550 project

DDB1

ENSG00000167986 - damage specific DNA binding protein 1

DCAF6

ENSG00000143164 - DDB1 and CUL4 associated factor 6

DDB1 associations

Associations for DDB1_associations

DCAF10

ENSG00000122741 - DDB1 and CUL4 associated factor 10

DDB1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE102505 5 V 0 TUNICAMYCIN HUMAN DN

A Gene Set from LINCS

GSE166914 1 V 2 ABEMACICLIB HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.